CAPTRUST Financial Advisors’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$73.5K Buy
+11,170
New +$51.8K ﹤0.01% 3204

Other funds holding LFCR

CAPTRUST Financial Advisors's LFCR Position: Q3 2026 in Review

CAPTRUST Financial Advisors opened a new position in Lifecore Biomedical (LFCR) in Q3 2026: 11,170 shares worth $73.5K. The stake represents ﹤0.01% of the portfolio and ranks #3204 among its holdings.

105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

  • CAPTRUST Financial Advisors held 11,170 shares of Lifecore Biomedical worth $73.5K as of Q3 2026.
  • Lifecore Biomedical was a new CAPTRUST Financial Advisors position in Q3 2026.
  • Lifecore Biomedical made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3204 holding.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.